Terns Pharmaceuticals Inc (TERN)
7.099
+0.16
(+2.29%)
USD |
NASDAQ |
Nov 04, 16:00
7.055
-0.04
(-0.62%)
After-Hours: 20:00
Terns Pharmaceuticals Shareholders Equity (Quarterly): 218.68M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 218.68M |
| March 31, 2024 | 236.72M |
| December 31, 2023 | 255.37M |
| September 30, 2023 | 258.42M |
| June 30, 2023 | 274.15M |
| March 31, 2023 | 287.68M |
| December 31, 2022 | 276.94M |
| September 30, 2022 | 183.69M |
| June 30, 2022 | 137.22M |
| Date | Value |
|---|---|
| March 31, 2022 | 148.72M |
| December 31, 2021 | 160.30M |
| September 30, 2021 | 172.16M |
| June 30, 2021 | 181.33M |
| March 31, 2021 | 190.00M |
| December 31, 2020 | 68.59M |
| September 30, 2020 | -24.85M |
| December 31, 2019 | 4.207M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-24.85M
Minimum
Sep 2020
287.68M
Maximum
Mar 2023
178.20M
Average
183.69M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Viking Therapeutics Inc | 911.45M |
| Biomarin Pharmaceutical Inc | 5.413B |
| Elite Pharmaceuticals Inc | 58.25M |
| Verrica Pharmaceuticals Inc | -13.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 230.88M |
| Total Liabilities (Quarterly) | 12.20M |